Dennis Schade
Impact in
- Biochemistry top 10%
- Eicosanoids and Hypertension Pharmacology
- Organic Chemistry top 10%
Papers in
-
- TGF-β signaling in diseases 7
- Pluripotent Stem Cells Research 7
- Cancer-related gene regulation 6
- CRISPR and Genetic Engineering 5
- Congenital heart defects research 5
- Physiology 10
- Nitric Oxide and Endothelin Effects 10
- Co-authors
- Bernd Clement (19 shared papers)Joscha Kotthaus (9 shared papers)Erik Willems (6 shared papers)Mark Mercola (4 shared papers)John R. Cashman (3 shared papers)Marion Lanier (3 shared papers)Paul Bushway (2 shared papers)Walter Raasch (3 shared papers)
- Journals
- Journal of Medicinal Chemistry (11 papers)ChemMedChem (5 papers)Bioorganic & Medicinal Chemistry (4 papers)ACS Pharmacology & Translational Science (2 papers)Planta Medica (2 papers)
- Partner nations
- GermanyUnited StatesNetherlands
In The Last Decade
Dennis Schade
47 papers receiving 963 citations
Peers
Comparison fields: 5 of 91
- Biochemistry 75
- Organic Chemistry 240
- Molecular Biology 568
- Oncology 119
- Physiology 107
Countries citing papers authored by Dennis Schade
This map shows the geographic impact of Dennis Schade's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dennis Schade with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dennis Schade more than expected).
Fields of papers citing papers by Dennis Schade
This network shows the impact of papers produced by Dennis Schade. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dennis Schade. The network helps show where Dennis Schade may publish in the future.
Co-authors
The 25 scholars most cited alongside Dennis Schade, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 106 | |
| 2 | 2017 | 91 | |
| 3 | 2015 | 79 | |
| 4 | 2014 | 74 | |
| 5 | 2010 | 74 | |
| 6 | 2012 | 59 | |
| 7 | 2011 | 52 | |
| 8 | 2018 | 43 | |
| 9 | 2010 | 33 | |
| 10 | 2013 | 30 | |
| 11 | 2008 | 28 | |
| 12 | 2015 | 21 | |
| 13 | 2008 | 21 | |
| 14 | 2015 | 19 | |
| 15 | 2011 | 18 | |
| 16 | 2019 | 16 | |
| 17 | 2020 | 16 | |
| 18 | 2011 | 15 | |
| 19 | 2019 | 15 | |
| 20 | 2015 | 15 |
About Dennis Schade
Dennis Schade is a scholar working on Molecular Biology, Physiology, Oncology, Organic Chemistry and Biochemistry, having authored 49 papers that have together received 973 indexed citations. Recurring topics across this work include Nitric Oxide and Endothelin Effects (10 papers), TGF-β signaling in diseases (7 papers), Pluripotent Stem Cells Research (7 papers), Cancer-related gene regulation (6 papers), CRISPR and Genetic Engineering (5 papers), Congenital heart defects research (5 papers), Eicosanoids and Hypertension Pharmacology (5 papers) and Drug Transport and Resistance Mechanisms (4 papers). The work is most often cited by research in Biochemistry (75 citations), Organic Chemistry (240 citations), Molecular Biology (568 citations), Oncology (119 citations) and Physiology (107 citations). Dennis Schade has collaborated with scholars based in Germany, United States and Netherlands. Frequent co-authors include Bernd Clement, Joscha Kotthaus, Erik Willems, Mark Mercola, John R. Cashman, Marion Lanier, Paul Bushway, Walter Raasch, Helge Müller‐Fielitz and Tanja Bange. Their work appears in journals such as Journal of Medicinal Chemistry, ChemMedChem, Bioorganic & Medicinal Chemistry, ACS Pharmacology & Translational Science and Planta Medica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.